AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Myofascial Release Technique in Women With Primary Dysmenorrhea

RecruitingNAAges 18 Years - 35 YearsFemaleGazi University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide, * Having regular menstruation in the last 6 months (28ยฑ7 days) * Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months Exclusion Criteria: * Diagnosed with Secondary Dysmenorrhea, * Having given birth, * Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes, * Undergoing urogynecological surgery, * Those who are pregnant or suspected of pregnancy, * Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain, * Those using intrauterine or oral contraceptives, * Those taking extra supplements such as magnesium, which may affect treatment
๐Ÿ’Š

What it tests

  • Myofascial Release
  • Sham-Myofascial Release
๐Ÿ“

Where

1 site
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Gazi University
Ankara, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy